Second-Line Chemotherapy Combined With Endostatin for Recurrent/Metastatic HN Epithelial Tumors

Clinical trial NCT03989830 · UNKNOWN

Trial details

NCT number: NCT03989830
Sponsor: Sun Yan
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Neoplasms

Start date: 2019-07-29
Primary completion: 2021-06-30
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.